Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · IEX Real-Time Price · USD
50.90
+0.80 (1.60%)
At close: Jul 19, 2024, 4:00 PM
50.89
-0.01 (-0.02%)
Pre-market: Jul 22, 2024, 7:45 AM EDT
Viking Therapeutics Employees
Viking Therapeutics had 27 employees as of December 31, 2023. The number of employees increased by 6 or 28.57% compared to the previous year.
Employees
27
Change (1Y)
6
Growth (1Y)
28.57%
Revenue / Employee
n/a
Profits / Employee
-$3,471,111
Market Cap
5.61B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 27 | 6 | 28.57% |
Dec 31, 2022 | 21 | 3 | 16.67% |
Dec 31, 2021 | 18 | -2 | -10.00% |
Dec 31, 2020 | 20 | 3 | 17.65% |
Dec 31, 2019 | 17 | -1 | -5.56% |
Dec 31, 2018 | 18 | 4 | 28.57% |
Dec 31, 2017 | 14 | 2 | 16.67% |
Dec 31, 2016 | 12 | 2 | 20.00% |
Dec 31, 2015 | 10 | 6 | 150.00% |
Jun 15, 2014 | 4 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
R1 RCM | 30,000 |
Acadia Healthcare Company | 23,500 |
DENTSPLY SIRONA | 15,000 |
Bausch + Lomb | 13,300 |
Organon & Co. | 10,000 |
Option Care Health | 7,802 |
Stevanato Group | 5,634 |
Masimo | 3,800 |
VKTX News
- 4 days ago - Viking Therapeutics to Report Financial Results for Second Quarter 2024 on July 24, 2024 - PRNewsWire
- 4 weeks ago - Viking Therapeutics Presents Preclinical Data on Novel Dual Amylin and Calcitonin Receptor Agonists at 84th Scientific Sessions of the American Diabetes Association - PRNewsWire
- 6 weeks ago - Viking Therapeutics reports promising data for liver disease drug - Invezz
- 6 weeks ago - Viking Therapeutics Announces Positive 52-Week Histologic Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH) - PRNewsWire
- 7 weeks ago - Viking Therapeutics to Participate at Upcoming Investor Conferences - PRNewsWire
- 2 months ago - Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance - CNBC
- 3 months ago - Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 3 months ago - Best biotech stocks to buy and hold in 2024: VKTX, SANA, RXRX - Invezz